ImmunityBio IBRX
NASDAQ IBRX
$8.83 +0.31 (+3.64%)
At close: Sep 29, 2026 · 4:00 PM EDT

ImmunityBio (IBRX) Total Current Liabilities (2014 - 2026)

Updated

ImmunityBio (IBRX) reported Total Current Liabilities of $76.73 million for Q2 2026, up 51.5% from $50.64 million a year earlier and up 12.9% from the prior quarter.

Analysis

ImmunityBio (IBRX) Total Current Liabilities (2014 - 2026) Analysis & Trends

At the end of FY2025, ImmunityBio posted Total Current Liabilities of $61.75 million, up 12.4% from FY2024.

  • Total Current Liabilities has a five-year compound annual growth rate of -1.9% (FY2020 to FY2025).
  • By year, Total Current Liabilities came in at $54.94 million in FY2024 (-5.7%), $58.28 million in FY2023 (-88.4%), $500.86 million in FY2022 (+35.7%) and $369 million in FY2021 (+441.6%).
  • The Q2 2026 figure ranks as the highest quarterly Total Current Liabilities since Q3 2023.
  • Year over year, Total Current Liabilities has now increased in each of the last three quarters, with growth averaging 3.8% over the last eight quarters.
  • The high point for year-over-year Total Current Liabilities in five years was Q4 2021 (growth of 441.6%); the low point was Q1 2024 (a decline of 90.5%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $67.95 million (Q1 2026), $61.75 million (Q4 2025) and $57.13 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 54.90 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 41.64 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 27.73 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 31.75 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -31.55 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 25.50 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 11.02 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 32.65 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 3.94 Bn
10 ImmunityBio 8.97 Bn 7.74 Bn 50.94 Mn 76.73 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 76.73 Mn
Mar 31, 2026 67.95 Mn
Dec 31, 2025 61.75 Mn
Sep 30, 2025 57.13 Mn
Jun 30, 2025 50.64 Mn
Mar 31, 2025 49.21 Mn
Dec 31, 2024 54.94 Mn
Sep 30, 2024 60.96 Mn
Jun 30, 2024 62.11 Mn
Mar 31, 2024 53.76 Mn
Dec 31, 2023 58.28 Mn
Sep 30, 2023 90.32 Mn
Jun 30, 2023 613.48 Mn
Mar 31, 2023 564.95 Mn
Dec 31, 2022 500.86 Mn
Sep 30, 2022 70.84 Mn
Jun 30, 2022 376.05 Mn
Mar 31, 2022 381.01 Mn
Dec 31, 2021 369.00 Mn
Sep 30, 2021 65.41 Mn
API Access

ImmunityBio Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=IBRX&period=max&api_key=YOUR_API_KEY